Biotechnology & Life Sciences Global On demand · 24-48h

Global DNA/RNA Extraction Equipment Market Strategic Research Report

Global DNA/RNA Extraction Equipment Market Strategic Researc…
$3,500 USD
Market Research Reports
Strategic Research Report
Global DNA/RNA Extraction Equipment Market
$6672025
6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Automated, Manual

By Application: Hospital, Laboratory, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Roche Life Science, Thermo Fisher Scientific, Qiagen, PerkinElmer, LGC, Promega, Kurabo Biomedical, Bruker (Hain), Analytik Jena, Bioneer, AutoGen, Biosan, ELITech, Genolution, GeneReach, Xian Tianlong, Tiangen, Bio-Germ

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 139 pages
Market size 2025
$667
Million USD
Forecast CAGR
6%
2025-2032
Forecast 2032
$1002.9
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global DNA/RNA Extraction Equipment market size is predicted to grow from US$ 667 million in 2025 to US$ 998 million in 2032; it is expected to grow at a CAGR of 6.0% from 2026 to 2032.

DNA/RNA Extraction Equipment greatly simplifies the process of isolating pure nucleic acids and/or proteins from a wide variety of natural sources.In 2024, global DNA/RNA Extraction Equipment production reached approximately 19.18 k units, with an average global market price of around US$ 31700 perunit.

With the increasing global focus on genomics research and precision medicine, the DNA/RNA extraction equipment market has ushered in unprecedented development opportunities. In particular, in the early diagnosis and personalized treatment of cancer, infectious diseases, and genetic disorders, nucleic acid extraction technology plays a crucial role. In addition, advancements in automation and high-throughput technologies have made the extraction process more efficient and standardized, further driving market growth. With continuous technological progress, the performance and reliability of equipment have improved, meeting laboratories' demand for high-quality nucleic acid samples.

Despite the promising market prospects, the DNA/RNA extraction equipment industry faces several challenges. Firstly, the high cost of equipment may limit the purchasing ability of small and medium-sized laboratories. Secondly, with the rapid development of technology, the speed of equipment updates accelerates, which may shorten the return on investment cycle. In addition, stringent global regulatory requirements for equipment quality and performance pose higher demands on enterprises' research and development and production.

Downstream demand primarily comes from clinical diagnostics, research institutions, pharmaceutical companies, and forensic laboratories. With the rise of personalized medicine and precision therapy, the demand for high-quality nucleic acid samples continues to increase. Moreover, the growing aging population globally is driving the demand for chronic and genetic disease testing, thereby boosting the demand for DNA/RNA extraction equipment.

The main raw materials for DNA/RNA extraction equipment include high-purity reagents, precision mechanical components, and high-performance electronic components. With technological advancements, the requirements for raw materials are continually increasing. For example, the introduction of automation systems raises higher demands on the performance of electronic components, while high-throughput processing capabilities require higher purity reagents and more precise mechanical components. Therefore, the stable supply and high-quality control of raw materials are key factors affecting equipment performance and market competitiveness.

This report presents a comprehensive overview of the global DNA/RNA Extraction Equipment market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Automated
  • Manual

Segment by Application

  • Hospital
  • Laboratory
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global DNA/RNA Extraction Equipment market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Laboratory, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global DNA/RNA Extraction Equipment Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$667
2025
Forecast
$1002.9
2032
CAGR
6%
2025–2032
Regions
5
global
Key companies
Roche Life ScienceThermo Fisher ScientificQiagenPerkinElmerLGCPromegaKurabo BiomedicalBruker (Hain)
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
AutomatedManual
By Application
HospitalLaboratoryOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Automated
  • 3.1.3 Manual
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Laboratory
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Roche Life Science
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Thermo Fisher Scientific
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Qiagen
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 PerkinElmer
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 LGC
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Promega
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Kurabo Biomedical
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Bruker (Hain)
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Analytik Jena
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Bioneer
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 AutoGen
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Biosan
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 ELITech
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Genolution
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 GeneReach
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Xian Tianlong
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Tiangen
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Bio-Germ
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global DNA/RNA Extraction Equipment market?
The global DNA/RNA Extraction Equipment market is estimated at US$ 667 million in 2025 (base year) and is projected to reach US$ 998 million by 2032.
What is the forecast CAGR for the DNA/RNA Extraction Equipment market?
The market is expected to grow at a CAGR of 6.0% from 2026 to 2032, expanding from US$ 667 million in 2025 to US$ 998 million in 2032, roughly 1.5 times its base-year value.
What is DNA/RNA Extraction Equipment?
DNA/RNA Extraction Equipment greatly simplifies the process of isolating pure nucleic acids and/or proteins from a wide variety of natural sources.In 2024, global DNA/RNA Extraction Equipment production reached approximately 19.18 k units, with an average global market price of around US$ 31700 perunit.
What are the main segments of the DNA/RNA Extraction Equipment market by type?
By type, the market is segmented into Automated and Manual.
Which applications drive demand in the DNA/RNA Extraction Equipment market?
Key applications covered include Hospital, Laboratory and Other.
Who are the key players in the DNA/RNA Extraction Equipment market?
Key players profiled include Roche Life Science, Thermo Fisher Scientific, Qiagen, PerkinElmer, LGC, Promega, Kurabo Biomedical and Bruker (Hain), among 18 companies covered in total.
Which regions and countries are covered for DNA/RNA Extraction Equipment?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the DNA/RNA Extraction Equipment market?
In addition, advancements in automation and high-throughput technologies have made the extraction process more efficient and standardized, further driving market growth.
What challenges does the DNA/RNA Extraction Equipment market face?
Despite the promising market prospects, the DNA/RNA extraction equipment industry faces several challenges.
Who should buy the DNA/RNA Extraction Equipment market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital, Laboratory and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the DNA/RNA Extraction Equipment market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.